Populations with skin color face particular challenges due to photocarcinoma, which includes skin cancers caused or accelerated by ultraviolet radiation. Even though melanated skin provides some inherent photoprotection, people in these groups are still susceptible to cancer; in fact, their cases frequently show delayed detection, unusual presentation, and poorer prognoses. This chapter examines the clinical presentation and epidemiology of photocarcinoma in people of color, highlighting the ways in which underrepresentation in studies has led to diagnostic blind spots. It looks at the modifying effects of melanin, the interplay of environmental and socioeconomic factors, and patterns of incidence both globally and regionally. Photocarcinomas in darker skin phototypes can show subtle early symptoms in clinical settings, which can result in late-stage diagnoses with substantial morbidity. This chapter emphasizes the importance of increased clinical vigilance, culturally sensitive communication, and inclusive screening practices by addressing analytical diagnostic pitfalls and providing illustrative case examples. To prevent and treat photocarcinoma, it ultimately promotes a paradigm change away from presumptions of “natural protection” and toward proactive identification and fair treatment.